Sign In
Buy ARCT
$7.60
-0.0500 (-0.654%)
At Close: Jun 03, 2026
Why Arcturus Therapeutics Stock Soared Today
03:46pm, Tuesday, 10'th Nov 2020
The biotech reported promising results for its coronavirus vaccine candidate.
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q3 2020 Results - Earnings Call Transcript
10:30pm, Monday, 09'th Nov 2020
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q3 2020 Results - Earnings Call Transcript
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q3 2020 Results - Quick Version Earnings Call Transcript
07:46pm, Monday, 09'th Nov 2020
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q3 2020 Results - Quick Version Earnings Call Transcript
Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
08:00am, Wednesday, 04'th Nov 2020
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #Clinicaltrial--Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
Arcturus Therapeutics to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Nov 9, 2020
09:00am, Friday, 30'th Oct 2020
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #Clinicaltrial--Arcturus Therapeutics to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Nov 9, 2020
Béisbol, sóftbol y 5G para todos. T‑Mobile aumenta las donaciones para la Little League® durante la Serie Mundial
12:00am, Tuesday, 20'th Oct 2020
El Un‑carrier está duplicando su compromiso de apoyar a los niños y niñas en momentos difíciles en los que familias de todo el país cuentan con presup
Walmart Anuncia Planes para Satisfacer las Necesidades Cambiantes de los Clientes en esta Temporada de Compras para las Fiestas
12:00am, Wednesday, 23'rd Sep 2020
Las fiestas han llegado a Walmart y el minorista se ha adaptado para satisfacer la evolución en las necesidades de sus clientes que planean comprar de
Coronavirus Vaccine Roundup, Early September
07:39am, Friday, 04'th Sep 2020
Taking a looking at the COVID-19 vaccine development landscape across various classes, including viral vectors, genetic vaccines, recombinant protein vaccines, attenuated virus vaccines, inactivated v
Arcturus Therapeutics Ltd. (ARCT) Investor Presentation - Slideshow
03:03pm, Thursday, 03'rd Sep 2020
The following slide deck was published by Arcturus Therapeutics Holdings Inc. in conjunction with this event..
Arcturus Therapeutics Executes Definitive Supply Agreement with the Israeli Ministry of Health
01:00pm, Tuesday, 18'th Aug 2020
SAN DIEGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on
Why Pfizer's 4% Yield Is Your Best Covid-19 Vaccine Play
12:24pm, Thursday, 13'th Aug 2020
I demonstrate why Pfizer is the best choice for dividend investors playing the Covid-19 vaccine theme.
SG Americas Securities LLC Buys Shares of 7,380 Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
01:10pm, Tuesday, 11'th Aug 2020
SG Americas Securities LLC purchased a new stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securitie
Potential for highly differentiated COVID-19 vaccine profile with a single administration, at a low dose Clinical study data expected in Q4 2020 SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Arcturus T
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Misses Revenue Estimates
09:25pm, Monday, 10'th Aug 2020
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of -3.77% and -54.31%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Arcturus Therapeutics Announces Second Quarter 2020 Financial Results and Provides a Corporate Update
08:01pm, Monday, 10'th Aug 2020
COVID-19 STARR™ mRNA vaccine candidate, ARCT-021 (LUNAR-COV19) has initiated Phase 1/2 clinical study with Duke-NUS Medical School; Dosing anticipated imminently, initial data expected Q4 ARCT-810
